Prostate Cancer Screening Reduces Risk
Screening with the prostate specific antigen PSA test reduced mortality risk in six trials involving nearly 800,000 men. The source stated the screening reduced price, but did not specify the cost reduction.
Topics
Developing
- 866d Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore.
- 866d Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
- 866d Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est.
- 866d Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium.
Sources · 7 independent
1010 WINS NYC
“and medical complications. In a preview that analyze six trials involving nearly 800,000 men, screening with the prostate specific antigen PSA test, reduced price.”
1010 WINS NYC
“800,000 men, screening with the prostate specific antigen PSA test, reduced price.”
Unlock the full story
Get a Pro subscription or above to see the live story progression and the full list of independent sources confirming each event as they happen.
Log in to upgrade